We develop novel algorithms for analyzing biomedical images, videos, and sensor data, tailored to your project requirements.
We develop end-to-end solutions, deployed in your favorite local or cloud-based environment.
We work as an extended part of your team, and treat every project as if it were one of our own.
Come visit us at booth #702, and see our poster titled "Artificial Intelligence Method Enables Evaluation of Both Acute and Chronic Drug Effects."
Come see our poster T-3222 titled "Artificial Intelligence Captures Structural Toxicity in Human In Vitro Cell Models on Thursday June 27 at 7pm in Poster Session II Even.
Come visit us at booth #2312, and see our poster P365 titled "A Novel Tool For Structural Toxicity Testing With In Vitro Models" on Thursday March 14 from 8:30am to 11:30am.
Dana Solutions announced today that it has entered into a Research Collaboration Agreement with the US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research.
We were invited to present to researchers at the Gladstone Institutes, and talk about how PhenoLearn can be used for image-based phenotypic modeling, drug screening, quality control, and more.
3505 El Camino Real
Palo Alto, CA 94306